Evidence map›Paper›PMID 34869606›Full record

ReviewFrontiers in molecular biosciences2021

Molecular Mechanisms of the RECQ4 Pathogenic Mutations.

Xiaohua Xu, Chou-Wei Chang, Min Li, Chao Liu, Yilun Liu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xiaohua XuDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, United States.
Chou-Wei ChangDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, United States.
Min LiDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, United States.
Chao LiuDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, United States.
Yilun LiuDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, United States.
Cancer Genetics (United States) · USBeckman Research InstituteCity of Hope · US

Funding

Regulation of Ionizing Radiation-Induced DNA Damage ResponseR01CA130899 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, YILUN · 2009 to 2023
$5.5M
DNA Damage Response and Oncogenic SignalingT32CA186895 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BINGHUI SHEN, Jeremy Michael Stark · 2016 to 2026
$2.1M
RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflictsR01CA225843 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI LIU, YILUN · 2019 to 2023
$2.0M
The function of Topoisomerase I SUMOylation in transcription and chemoresistanceR01GM127602 · NIGMS · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI LIU, YILUN · 2018 to 2021
$1.4M
NCI NIH HHS R01 CA130899NCI NIH HHS R01 CA225843NCI NIH HHS T32 CA186895NIGMS NIH HHS R01 GM127602
6 · The paper itself

Abstract

The human

Indexed as

agingcancerDNA repairDNA replicationmitochondriaRECQ helicase

Identifiers

PMID34869606
PMCPMC8637615
OpenAlexW3216717589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.